Dr. Stavros Lomvardas's lab at Columbia University focuses on understanding how olfactory receptors work at the molecular level and how they influence brain connections. The team conducts research on gene expression in sensory neurons and how these processes can lead to precise brain functions. Their work has important implications for treating neurodevelopmental disorders and understanding the basic biology of the sense of smell.

The research lab led by Filippo Mancia at Columbia University focuses on understanding the molecular mechanisms of drug resistance in malaria and the transport of signaling molecules known as Wnts. By employing advanced techniques such as cryo-electron microscopy, gene editing, and imaging, the lab explores how specific proteins interact with drugs and each other, aiming to develop better treatments for malaria and uncover the factors that influence cell signaling. Their work combines structural biology, computational modeling, and biochemical assays to shed light on these critical processes.

Dr. Jennifer Manly's lab at Columbia University focuses on understanding the reasons behind racial disparities in Alzheimer's disease and related cognitive impairments. The lab studies how social and biological factors influence cognitive health, particularly in middle-aged adults from diverse backgrounds. By examining data from a large group of participants, they aim to identify ways to mitigate risks and improve outcomes for those affected by these disparities.

The Mann lab at Columbia University studies how certain genes, known as Hox genes, control the identities of different body parts in fruit flies, which helps us understand how animals develop. They combine techniques from genetics, biochemistry, and genomics to decipher the roles of these genes at a very detailed level. Through this research, they also explore the mechanisms that could be relevant to human diseases caused by gene regulation issues, like cancer and diabetes.

Dr. James Mccallum Noble's lab is focused on understanding the links between oral health, specifically periodontal infections, and Alzheimer's Disease. They are investigating how periodontitis may contribute to cognitive impairment and dementia in older adults. By studying a diverse group of elderly participants over time, they aim to uncover potential mechanisms connecting these two health issues and provide insights for prevention and early intervention strategies.

Dr. Laura F Landweber's lab at Columbia University focuses on understanding how natural processes in tiny organisms called microbial eukaryotes, like Oxytricha, edit their genomes. They explore complex ways DNA and RNA are processed and rearranged, shedding light on genetic diversity and evolution. This research is important because it can reveal insights into genetic disorders and cancers seen in humans.

Gary Struhl's lab at Columbia University focuses on understanding how signaling molecules, known as morphogens, control the growth and patterning of organs during development using the fruit fly Drosophila as a model organism. The research explores the complex interactions between these morphogens, their receptors, and the genetic elements they regulate, aiming to uncover insights that could inform therapeutic strategies for various human diseases, particularly developmental disorders and cancers.

Dr. George Z Mentis's lab focuses on understanding how neuronal circuits control movement and how their dysfunction can lead to diseases like spinal muscular atrophy (SMA). The research explores the mechanisms of synaptic dysfunction and the roles of specific neurons in locomotion, aiming to reveal insights into the underlying causes of motor deficits. By using mouse models, the lab seeks to uncover crucial cellular and molecular interactions that contribute to motility disorders, potentially illuminating new therapeutic targets for neurodegenerative diseases.

Dr. Hynek Wichterle's lab at Columbia University focuses on understanding how human spinal motor neurons develop and mature, particularly in comparison to mouse motor neurons. The research aims to identify key molecular mechanisms that contribute to the formation of motor neurons and their susceptibility to diseases like ALS. By engineering specific proteins that could enhance neuron maturation from stem cells, the lab hopes to develop better models of neurodegenerative diseases and explore potential therapeutic strategies.

Dr. Haikel Dridi's lab at Columbia University focuses on understanding the cellular mechanisms behind skeletal muscle weakness and fatigue, particularly in the context of heart failure. The lab investigates how calcium signaling, specifically through ryanodine receptor type 1 channels, impacts muscle contraction in failing hearts. By studying these mechanisms, the research aims to identify potential therapeutic targets to improve muscle function and quality of life for individuals suffering from heart failure.

Dr. Martin Chalfie's lab at Columbia University focuses on understanding how nerve cells differentiate and function using the model organism, the nematode worm Caenorhabditis elegans. His research explores genetic mechanisms behind neuronal development, particularly in touch receptor neurons, and how these insights could relate to human health and disease. The lab employs advanced techniques to analyze gene functions that may enhance our understanding of mechanosensation and the cellular processes involved in nervous system disorders.

Dr. Thomas P. Maniatis's lab studies how specific genes help form the connections between neurons in the brain during development. They focus on a group of genes known as protocadherins, which give neurons unique identities necessary for building proper neural circuits. By investigating how mutations in these genes can affect brain wiring, the research aims to understand their role in neurodevelopmental disorders such as autism and schizophrenia. Overall, the lab seeks to uncover the underlying mechanisms that could lead to new treatments for these conditions.

Dr. Natura Myeku's lab at Columbia University Health Sciences investigates how specific proteins degrade in neurodegenerative diseases like Alzheimer's. The research focuses on understanding the roles of specialized proteins called immunoproteasomes, especially during inflammation, and how their dysfunction might contribute to disease progression. The lab combines advanced techniques to unravel the mechanisms behind protein accumulation that characterizes diseases of aging.

Dr. Francesca Bartolini's lab at Columbia University focuses on understanding the mechanisms behind Alzheimer's disease and chemotherapy-induced peripheral neuropathy (CIPN). By studying how microtubule stability and tubulin modifications impact neuronal health, the lab aims to uncover new pathways that could lead to effective treatments for these conditions.

The lab of Mijo Simunovic focuses on creating realistic models of human organ development using advanced techniques in stem cell biology and tissue engineering. They aim to understand how organs form by studying the gut tube and its neighboring organs, utilizing precise signaling methods to recreate the development process in the lab. Their innovative approaches may lead to new treatments and technologies for regenerative medicine and high-throughput drug screening.

Dr. Livio Pellizzoni's lab focuses on understanding spinal muscular atrophy (SMA), a genetic disease that leads to motor neuron deterioration and muscle atrophy. The research aims to uncover the underlying mechanisms of SMA and identify new therapeutic approaches to improve treatment outcomes for affected individuals. By studying RNA-mediated processes and developing potential drug combinations, the lab seeks to address significant challenges in the management of SMA.

Dr. Hemali Phatnani's lab at Columbia University Health Sciences focuses on understanding the mechanisms behind neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The lab investigates how protein aggregation—especially that of TDP-43—can lead to damage in nerve cells and contributes to these diseases. They aim to uncover the physical and molecular changes that predispose certain cells to disease and develop new treatment strategies that could improve patient outcomes.

Dr. Franck Polleux's lab at Columbia University focuses on understanding the development and evolution of brain circuits, particularly how unique human features emerge at the molecular level. The lab investigates how specific proteins and genes influence the structure and function of neurons and synapses, which could reveal insights into the biology of human cognitive capabilities and disorders. Through their research, they aim to uncover the cellular mechanisms involved in brain development and their implications for neurodevelopmental and neurodegenerative diseases.

Dr. Joriene De Nooij's lab at Columbia University is focused on understanding the development and function of proprioceptors, which are specialized sensory neurons that help our body sense position and movement. They study how these neurons develop different identities based on the types of sensory information they receive. By exploring the genetic and molecular dynamics involved in this process, their research aims to improve treatment strategies for spinal cord injuries and enhance our understanding of movement control in the nervous system.

Dr. Gennarino's lab focuses on understanding the role of the PUM1 gene in different neurological disorders. They study how various mutations in this gene lead to distinct symptoms, such as mild ataxia or severe developmental disorders. By creating mouse models and examining human cases, the lab aims to uncover the underlying molecular mechanisms that lead to these diverse phenotypes.